Cassava Sciences, Inc.
US ˙ NasdaqCM ˙ US14817C1071
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecuritySAVA / Cassava Sciences, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership559,205 shares
Latest Disclosed Value $ 945,056
D. E. Shaw & Co., Inc. ownership in SAVA / Cassava Sciences, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 559,205 shares of Cassava Sciences, Inc. (US:SAVA) valued at $945,056 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 469,326 shares of Cassava Sciences, Inc.. This represents a change in shares of 19.15% during the quarter. The current value of the position is $1,330,908 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (SAVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SAVA / Cassava Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FILANA THERAPEUTICS COM 14817C107 559,205 89,879 19.15 945 1.72 0.0006
2026-02-17 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 469,326 469,326 929 0.0005
2024-11-14 2023-12-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 0 -16,553 -100.00 0 -100.00
2024-02-14 2023-12-31 13F CASSAVA SCIENCES COM 14817C107 0 -16,553 0
2023-11-14 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 16,553 3,417 26.01 275 -14.60 0.0003
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 13,136 13,136 322 0.0003
2022-08-15 2022-06-30 13F CASSAVA SCIENCES COM 14817C107 0 -44,400 -100.00 0 -100.00
2022-05-16 2022-03-31 13F CASSAVA SCIENCES COM 14817C107 44,400 44,400 1,649 0.0015
2022-02-14 2021-12-31 13F CASSAVA SCIENCES COM 14817C107 0 -49,269 -100.00 0 -100.00
2021-11-15 2021-09-30 13F CASSAVA SCIENCES COM 14817C107 49,269 -10,721 -17.87 3,059 -40.32 0.0028
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 59,990 59,990 5,126 0.0044
2019-02-14 2018-12-31 13F PAIN THERAPEUTICS COM NEW 69562K506 0 -11,778 -100.00 0 -100.00
2018-11-14 2018-09-30 13F PAIN THERAPEUTICS COM NEW 69562K506 11,778 -977 -7.66 12 -53.85 0.0000
2018-08-14 2018-06-30 13F PAIN THERAPEUTICS COM NEW 69562K506 12,755 -2,902 -18.53 26 -76.58 0.0000
2018-05-15 2018-03-31 13F PAIN THERAPEUTICS COM NEW 69562K506 15,657 -2,300 -12.81 111 54.17 0.0002
2018-02-14 2017-12-31 13F PAIN THERAPEUTICS COM NEW 69562K506 17,957 -600 -3.23 72 -5.26 0.0001
2017-11-14 2017-09-30 13F PAIN THERAPEUTICS COM NEW 69562K506 18,557 0 0.00 76 0.00 0.0001
2017-08-14 2017-06-30 13F PAIN THERAPEUTICS COM NEW 69562K506 18,557 -140,922 -88.36 76 -46.48 0.0001
2017-05-15 2017-03-31 13F PAIN THERAPEUTICS COM 69562K100 159,479 -120,113 -42.96 142 -11.25 0.0002
2017-02-14 2016-12-31 13F PAIN THERAPEUTICS COM 69562K100 279,592 -51,480 -15.55 160 -51.66 0.0003
2016-11-14 2016-09-30 13F PAIN THERAPEUTICS COM 69562K100 331,072 -47,529 -12.55 331 -60.07 0.0006
2016-08-15 2016-06-30 13F PAIN THERAPEUTICS COM 69562K100 378,601 -15,344 -3.89 829 -5.69 0.0015
2016-05-16 2016-03-31 13F PAIN THERAPEUTICS COM 69562K100 393,945 1,100 0.28 879 27.76 0.0016
2016-02-16 2015-12-31 13F PAIN THERAPEUTICS COM 69562K100 392,845 0 0.00 688 -4.31 0.0010
2015-11-16 2015-09-30 13F PAIN THERAPEUTICS COM 69562K100 392,845 -12,246 -3.02 719 2.57 0.0011
2015-08-14 2015-06-30 13F PAIN THERAPEUTICS COM 69562K100 405,091 -79,603 -16.42 701 -23.47 0.0010
2015-05-15 2015-03-31 13F PAIN THERAPEUTICS COM 69562K100 484,694 -10,625 -2.15 916 -8.95 0.0014
2015-02-17 2014-12-31 13F PAIN THERAPEUTICS COM 69562K100 495,319 152,489 44.48 1,006 -24.93 0.0013
2014-11-14 2014-09-30 13F PAIN THERAPEUTICS COM 69562K100 342,830 -82,876 -19.47 1,340 -45.24 0.0017
2014-08-14 2014-06-30 13F PAIN THERAPEUTICS COM 69562K100 425,706 78,296 22.54 2,447 28.05 0.0033
2014-05-15 2014-03-31 13F PAIN THERAPEUTICS COM 69562K100 347,410 97,912 39.24 1,911 57.54 0.0027
2014-02-14 2013-12-31 13F PAIN THERAPEUTICS COM 69562K100 249,498 24,637 10.96 1,213 98.20 0.0017
2013-11-20 2013-09-30 13F/A-1 PAIN THERAPEUTICS COM 69562K100 224,861 7,327 3.37 612 27.23 0.0010
2013-11-14 2013-09-30 13F PAIN THERAPEUTICS COM 69562K100 224,861 612
2013-08-14 2013-06-30 13F PAIN THERAPEUTICS COM 69562K100 217,534 217,534 481 0.0009
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F CASSAVA SCIENCES COM Call 10,000 0.00 295 -29.43 n/a n/a n/a
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM Call 10,000 0.00 418 48.75 n/a n/a n/a
2022-08-15 2022-06-30 13F CASSAVA SCIENCES COM Call 10,000 0.00 281 -24.26 n/a n/a n/a
2022-05-16 2022-03-31 13F CASSAVA SCIENCES COM Call 10,000 0.00 371 -15.10 n/a n/a n/a
2022-02-14 2021-12-31 13F CASSAVA SCIENCES COM Call 10,000 0.00 437 -29.63 n/a n/a n/a
2021-11-15 2021-09-30 13F CASSAVA SCIENCES COM Call 10,000 0.00 621 -27.28 n/a n/a n/a
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM Call 10,000 854 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.